Changes to US Lovenox prescribing information

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1452, 2004-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Currently, the US FDA is not requiring changes to the prescribing information of Tysabri [natalizumab] or to the risk management plan

Reactions Weekly, Vol. 1, Iss. 1271, 2009-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Changes in antibacterial prescribing urgently needed in US

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 664, 2012-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Prescribing information revised for cerivastatin in the US and UK

Inpharma, Vol. 1, Iss. 1295, 2001-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

AMA seeks tighter control of prescribing information in the US

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 294, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Isotretinoin prescribing on the increase in the US

Inpharma, Vol. 1, Iss. 1340, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite